BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32394763)

  • 1. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
    Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP
    J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation Protocol for Secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation.
    Kimura T; Tucker A; Nakagaki A; Sugimura T; Fukuda S; Katsuno M; Fujita T; Izumi N; Suzuki N; Sako K
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105893. PubMed ID: 34107414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.
    Subramanya V; Claxton JS; Lutsey PL; MacLehose RF; Chen LY; Chamberlain AM; Norby FL; Alonso A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):598. PubMed ID: 34915858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
    Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
    J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
    Anjum M; Ariansen I; Hjellvik V; Selmer R; Kjerpeseth LJ; Skovlund E; Myrstad M; Ellekjær H; Christophersen IE; Tveit A; Berge T
    Eur Heart J; 2024 Jan; 45(1):57-66. PubMed ID: 37995254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
    Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of Bleeding and Stroke Based on CHA2DS2-VASc Scores in Japanese Patients With Atrial Fibrillation: A Large-Scale Observational Study Using Real-World Data.
    Maeda T; Nishi T; Funakoshi S; Tada K; Tsuji M; Satoh A; Kawazoe M; Yoshimura C; Arima H
    J Am Heart Assoc; 2020 Mar; 9(5):e014574. PubMed ID: 32106743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
    Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
    BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP; Saba S; Zhang Y; Hernandez I
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.
    O'Neal WT; Sandesara PB; Claxton JS; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016.
    Newman TV; Chen N; He M; Saba S; Hernandez I
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):471-479. PubMed ID: 31808136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study.
    Choi SY; Kim MH; Lee KM; Cho YR; Park JS; Yun SC; Lip GYH
    Thromb Haemost; 2021 Sep; 121(9):1151-1160. PubMed ID: 33307565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
    Gennaro N; Ferroni E; Zorzi M; Denas G; Pengo V
    Int J Cardiol; 2024 Jan; 394():131369. PubMed ID: 37722453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
    Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
    BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study.
    Chen YL; Lin YS; Wang HT; Liu WH; Chen HC; Chen MC
    Europace; 2019 Feb; 21(2):313-321. PubMed ID: 30107472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.